KIMCo jointly invests $1.7 mil. in US biotech firm GenEdit
The Korea Innovative Medicines Consortium (KIMCo) said Monday that it would conduct a joint investment project to help strengthen the Korean biopharmaceutical industry’s global competitiveness.